Clinical Trials
Single Dose of Regen-Cov Provides Long-Term Protection Against COVID-19
Single dose of REGEN-COV (1,200 mg subcutaneous) reduced the risk of COVID-19 by 81.6% during the pre-specified follow-up period (months 2-8), maintaining the 81.4%...
News
Envirotainer Opens a New station in Guangzhou, China
Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, announced that they are opening a new station in...
Press Releases
India sees sizable improvement in finished dosage reputation and growth ahead of CPhI India 2021
CPhI & P-MEC India – organised by Informa Markets – is set to welcome attendees and exhibitors from around the world, both online and...
News
UK to add Bharat Biotech’s Covaxin to approved vaccine list from November 22
Bharat Biotech's Covaxin will be added to UK government's list of approved COVID-19 vaccines for international travellers from November 22. This comes after Covaxin...
Press Releases
Beximco Pharma introduces world’s first generic molnupiravir, an oral antiviral drug for COVID-19 treatment
Beximco Pharmaceuticals Limited, the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces the launch of the world's first generic molnupiravir, an...
Drug Research
Biognosys Launches Next-Generation Blood Biomarker Discovery Solution
Biognosys, a leader in proteomics solutions for drug discovery and development, announces the launch of its next-generation blood biomarker discovery solution, which will be...
News
Canada authorizes Pfizer COVID vaccine booster for adults
Health Canada authorized the use of a booster dose of the Pfizer Inc (PFE.N) and BioNTech (22UAy.DE) COVID-19 vaccine for people aged 18 years...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read